Trending Articles

article thumbnail

New therapy for Huntington’s disease gets £35 million boost

Drug Discovery World

Biotechnology company LoQus23 Therapeutics has closed its £35 million (c.$43 million) Series A financing. The financing round was led by Forbion, alongside existing investors SV Health Investors’ Dementia Discovery Fund (DDF) and Novartis Venture Fund (NVF). Forbion General Partner Rogier Rooswinkel will join LoQus23’s Board of Directors. LoQus23 was founded in 2019 by Entrepreneurs in Residence at DDF Dr David Reynolds, Dr Caroline Benn, and Dr Ruth McKernan CBE, FMedSci and seeded by SV’s Deme

Disease 147
article thumbnail

Young Vilnius University Scientist I. Mogila Received Birnstiel Award for Breakthrough in CRISPR-Cas10 Research

Drug Discovery Today

Irmantas Mogila, a young scientist from Vilnius University (VU) Life Sciences Center (LSC), has joined the ranks of the most talented early-career life science researchers. He was given the prestigious international Birnstiel Award for his outstanding research results in the field of molecular biology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

£3m boost to paediatric brain cancer research

Drug Discovery World

Experts from Cancer Research UK Children’s Brain Tumour Centre of Excellence in Cambridge, UK are set to share around £3.2 ($4.2) million to find and test better and less toxic ways to treat children’s brain tumours. The funding announcement comes during Childhood Cancer Awareness Month. Brain tumours are the leading cause of cancer death in children and those that do survive often face life-changing side effects as a result of their treatment.

Research 258
article thumbnail

AI Uses Zero-Shot Learning to Find Existing Drugs for Treating Rare Diseases

Nvidia Developer: Drug Discovery

A groundbreaking drug-repurposing AI model could bring new hope to doctors and patients trying to treat diseases with limited or no existing treatment options. A groundbreaking drug-repurposing AI model could bring new hope to doctors and patients trying to treat diseases with limited or no existing treatment options. Called TxGNN, this zero-shot tool helps doctors find new uses for existing drugs for conditions that might otherwise go untreated.

Disease 144
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Wastewater bacteria can breakdown plastic for food

Science Daily: Pharmacology News

Comamonadacae is a family of bacteria often found growing on plastics in water. New study finds a bacterium in this family can break down the plastic for food. Researchers also identified the enzyme the bacterium use to degrade plastic. The discovery opens new possibilities for developing bacteria-based engineering solutions to help clean up difficult-to-remove plastic waste.

article thumbnail

Kailera Therapeutics emerges from stealth with $400M for obesity drugs

BioPharma Drive: Drug Pricing

The company’s official launch comes five months after major investors such as Atlas Venture and Bain Capital filed a Shanghai stock exchange filing for a biotech named “Hercules CM NewCo.

Drugs 124

More Trending

article thumbnail

This Season's Flu Vaccine Cuts Risk of Hospitalization by Almost 35%

Drugs.com

THURSDAY, Oct. 3, 2024, HealthDay News -- The Southern Hemisphere's flu season is winding down, and new data shows this year's flu shot was 34.5% effective in keeping folks there who got influenza from needing hospital care. Most (68.3%) of those.

Hospitals 111
article thumbnail

Bottlenose dolphins 'smile' at each other while playing

Science Daily: Pharmacology News

Dolphins are extremely playful, but little is known about how they -- and other marine mammals -- communicate during playtime. New research shows that bottlenose dolphins (Tursiops truncates) use the 'open mouth' facial expression -- analogous to a smile -- to communicate during social play. The dolphins almost always use the facial expression when they are in their playmate's field of view, and when playmates perceived a 'smile,' they responded in kind 33% of the time.

Research 116
article thumbnail

Roche turns to a startup in search for new breast cancer drugs

BioPharma Drive: Drug Pricing

The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to blockbuster medicines from Pfizer and Eli Lilly.

Drugs 116
article thumbnail

FDA awards grants to seven clinical trials for orphan products

Drug Discovery World

The US Food and Drug Administration (FDA) has announced seven new clinical trial grants awarded under the Orphan Products Grants Program for clinical trials to address the unmet needs of people affected by rare diseases. In total, clinical researchers will receive approximately $17.2 million over the next four years. Newly funded projects: Palvella Therapeutics received $2.6 million to fund a Phase III study of PTX-022 (Sirolimus) for the treatment of microcystic lymphatic malformations.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Innovative Trials CEO named top Woman in Pharma at the Pharma Industry Awards UK

Drug Discovery Today

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, has been crowned a top ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was given the award at a ceremony in Birmingham on Wednesday 18th September.

Trials 113
article thumbnail

CDC Warns of Fake Drug Dangers From Online Pharmacies

Drugs.com

THURSDAY, Oct. 3, 2024 -- Americans who turn to online pharmacies to find cheaper versions of expensive prescription medications, especially opioids, may instead be buying themselves dangerous drugs that could trigger an overdose, U.S. health.

article thumbnail

Study links hurricanes to higher death rates long after storms pass

Science Daily: Pharmacology News

U.S. tropical cyclones, including hurricanes, indirectly cause thousands of deaths for nearly 15 years after a storm. Researchers estimate an average U.S. tropical cyclone indirectly causes 7,000 to 11,000 excess deaths. All told, they estimate tropical storms since 1930 have contributed to between 3.6 million and 5.2 million deaths in the U.S. -- more than all deaths nationwide from motor vehicle accidents, infectious diseases, or battle deaths in wars during the same period.

Disease 113
article thumbnail

New Viral Vectors - Fall 2024

addgene Blog

If the fall colors are inspiring you to paint your cells in equally vivid colors, you'll want to check out the 34 new preps available in the Addgene viral vector repository! This includes the first Addgene prep packaged in the AAV9-X1.1 serotype.

Packaging 103
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

SGS to showcase integrated drug development solutions at CPhI Milan 2024

Drug Discovery World

This article is sponsored by SGS. Join SGS’s Health Science team at booth 5D82 to explore their integrated drug development solutions, from analytical testing to clinical research, formulation and manufacturing development. SGS is excited to announce its participation as an exhibitor where it will present its extensive range of quality and compliance services for the health science industry.

article thumbnail

New therapy that targets and destroys tau tangles is a promising future Alzheimer’s disease treatment

Drug Discovery Today

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer’s disease, and improve symptoms of neurodegeneration in mice.

Therapies 113
article thumbnail

Scientists Get Closer to Stopping Macular Degeneration

Drugs.com

WEDNESDAY, Oct. 2, 2024 -- Scientists say they've discovered a protein that seems crucial to the onset of age-related macular degeneration (AMD), a common cause of blindness in older people.The research is in its very early stages, but it might.

Research 111
article thumbnail

Research in 4 continents links outdoor air pollution to differences in children's brains

Science Daily: Pharmacology News

A research team systematically analyzed 40 empirical studies, the majority of which had found that outdoor air pollution is associated with differences in children's brains. These differences include volumes of white matter, which is associated with cognitive function, connections throughout the brain and even early markers for Alzheimer's.

Research 111
article thumbnail

FDA makes end of Zepbound, Mounjaro shortage official

BioPharma Drive: Drug Pricing

Removal of Lilly’s in-demand drugs from the FDA’s shortage list ramps up pressure on the companies selling compounded versions.

FDA 112
article thumbnail

Data support one-year efficacy of ND0612 in Parkinson’s disease

Drug Discovery World

New data from the Phase III BouNDless trial and its ongoing open-label extension (OLE) support the long-term efficacy of ND0612 in people with Parkinson’s disease (PD) experiencing motor fluctuations. The new clinical trial data was shared at the 2024 International Congress of Parkinson’s Disease and Movement Disorders (MDS). ND0612 is being studied as a 24-hour, continuous, subcutaneous (SC) infusion of liquid levodopa/carbidopa (LD/CD).

Disease 147
article thumbnail

Calculating the Regulatory Review Period for Patent Term Extension: A Comprehensive Guide

Drug Patent Watch

In the complex world of intellectual property and pharmaceutical development, understanding the intricacies of patent term extension (PTE) is crucial for innovators and businesses alike. One of the most critical aspects of PTE is calculating the regulatory review period, which can significantly impact the lifespan and profitability of a patented product.

article thumbnail

California Bans 6 Artificial Dyes in Foods Served at Public Schools

Drugs.com

TUESDAY, Oct. 1, 2024 -- A new law just passed in California makes it the first state to tell public schools they may no longer serve foods that contain six artificial dyes linked to health and behavior problems among children.Gov. Gavin Newsom.

111
111
article thumbnail

The true global impact of species-loss caused by humans is far greater than expected

Science Daily: Pharmacology News

The extinction of hundreds of bird species caused by humans over the last 130,000 years has led to substantial reductions in avian functional diversity -- a measure of the range of different roles and functions that birds undertake within the environment -- and resulted in the loss of approximately 3 billion years of unique evolutionary history, according to a new study.

104
104
article thumbnail

Q&A: How Terra became a backbone of public health pathogen surveillance

Broad Institute

Q&A: How Terra became a backbone of public health pathogen surveillance By Allessandra DiCorato September 30, 2024 Breadcrumb Home Q&A: How Terra became a backbone of public health pathogen surveillance Bronwyn MacInnis and Daniel Park reflect on how Terra, a scalable and secure open-source platform for biomedical data management and analysis, is making genomics accessible to public health labs.

article thumbnail

AskBio and Belief BioMed explore potential new gene therapies

Drug Discovery World

Bayer AG and Asklepios BioPharmaceutical (AskBio) have announced a new strategic collaboration with Belief BioMed (BBM) to explore the potential for new gene therapies. Under the terms of the contract, the companies will combine efforts and experience in gene therapy technology to explore potential therapies in diseases that may be treatable using a liver-targeted approach.

Therapies 147
article thumbnail

When Do Drug Patents Expire: Understanding the Lifecycle of Pharmaceutical Innovations

Drug Patent Watch

Have you ever wondered why some medications seem to cost an arm and a leg, while others are surprisingly affordable? The answer often lies in the complex world of drug patents. Let’s dive into the fascinating realm of pharmaceutical intellectual property and explore when drug patents expire. Drug patents are a crucial aspect of the pharmaceutical industry.

article thumbnail

GLP-1 Weight-Loss Meds Could Interfere With Endoscopy, Colonoscopy

Drugs.com

TUESDAY, Oct. 1, 2024 -- Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.Now, research finds this scenario is more likely if the patient is taking popular new.

Doctors 111
article thumbnail

Ant agriculture began 66 million years ago in the aftermath of the asteroid that doomed the dinosaurs

Science Daily: Pharmacology News

According to a new study, colonies of ants began farming fungi when an asteroid struck Earth 66 million years ago. This asteroid impact caused a global mass extinction but also created ideal conditions for fungi to thrive. Innovative ants began cultivating the fungi, creating an evolutionary partnership that became even more tightly intertwined 27 million years ago and continues to this day.

103
103
article thumbnail

Medical Coding in Clinical Data Management

Quanticate

In any clinical trial conduct, recording and storing data in a controlled, consistent, and reproducible manner for data retrieval and analysis is a necessity for regulatory compliance and clinical study success.

article thumbnail

£3m accelerates new drugs for lung infections in cystic fibrosis

Drug Discovery World

The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has announced the first cohort of drug discovery projects to receive its Collaborative Discovery Programme (CDP) funding. The £3 ($3.9) million programme, funded by LifeArc, will support six early-stage novel antimicrobial projects over two years to accelerate new treatments for lung infections in people with CF.

Drugs 147
article thumbnail

How are prescription drug prices determined?

Drug Patent Watch

In the world of healthcare, few topics spark as much debate and confusion as prescription drug pricing. Have you ever wondered why that little pill in your medicine cabinet costs so much? Let’s dive into the intricate world of pharmaceutical economics and uncover the factors that determine the price tags on our prescriptions.

Drugs 96
article thumbnail

Stem Cell Therapy Might Repair Vision-Robbing Holes in Retinas

Drugs.com

THURSDAY, Oct. 3, 2024 -- Japanese researchers have successfully used a transplant of human stem cells to close a hole in a key part of a monkey's retina. They say the achievement could pave the way for better treatment of small gaps that form in.

Therapies 103
article thumbnail

Green subsidies may have hidden costs, experts warn

Science Daily: Pharmacology News

Government subsidies for business practices and processes should be approached with caution, even when they seem to be environmentally friendly, writes a group of scientists and economists. They argue that subsidies can alter market pressures, leading to unintended consequences that not only perpetuate harmful subsidies over time but also diminish the overall effectiveness of those intended to promote environmental sustainability.

article thumbnail

How Roche plans to fill a projected $8B sales gap

BioPharma Drive: Drug Pricing

Biosimilar competition to aging blockbusters will erode a large chunk of the pharma giant’s top line over the next few years.